Skip navigation
>»
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Hepatology meetings & conferences

10 meetings & conferences listed in Hepatology 

15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)
Germany
06/26/2015

15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)

June 26-28, 2015 Berlin, Germany

In June 2015 the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) will be held in Berlin, Germany.

ISVHLD has a tradition of 43 years. Initially the focus was on discovery of hepatitis viruses, then it was the development of diagnostic procedures, vaccines, understanding pathophysiology and now therapies. In 2015 will be the time when many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. However public health will become very important to identify the patients in need for therapy and to make these new therapies accessible to all parts of the world. Furthermore we still need to develop better finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.

This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances made against the global health burden caused by all hepatitis viruses. For the first time the symposium will be organized in Germany taking place in its capital Berlin.

Hepatologist, Physician, Physician Researcher, Virologist
3rd World Congress on Controversies in the Management of Viral Hepatitis
Germany
05/01/2014

3rd World Congress on Controversies in the Management of Viral Hepatitis

May1-3, 2014 Berlin, Germany

The large attendance and enthusiastic feedback from the 1st Congress and in particular the 2nd Congress held in Berlin this October, illustrated the need for this unique meeting completely focusing on the needs of the busy clinician caring for HCV and HBV infected patients.

The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of the top world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, with emphasis on the appropriate use of new and emerging drugs.

This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge on these exciting advances.

The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.

Hepatologist, Internist, Physician, Primary Care Physician
3rd Latin American Meeting on Treatment of Viral Hepatitis
Brazil
06/06/2014

3rd Latin American Meeting on Treatment of Viral Hepatitis

6-7 June 2014 São Paulo, Brazil

This meeting promises again to become a unique high profile educational event with the contribution of key opinion leaders. We have set up a program for treating physicians to discuss the latest developments in the field of Hepatitis B and C treatment and the promising treatment possibilities of new antivirals that are becoming available. The conference presentations will focus on the translation of these new data and availability of new drugs into daily clinical practice. In addition, case discussions will be an important part of this conference, in order to stimulate discussions on local issues and stimulate interaction.

The target audience of this meeting consists of hepatologists, infectious disease doctors, gastro-enterologists and other healthcare professionals involved in daily care for Hepatitis-infected patients.

At the completion of this workshop the participant will:

- have an understanding of the basic concepts of Hepatitis B and C therapy

- be updated on the latest developments in the field of Hepatitis B and C antiviral research

- have an understanding of the challenges of Hepatitis B and C treatment in different patient populations

- have an overview of the advantages and possibilities of new antivirals in Hepatitis B and C therapy

- will know how to apply direct acting antivirals in clinical practice.

Gastroenterologist, Hepatologist, Physician, Physician Researcher
Singapore Hepatitis Conference
Singapore
06/06/2014

Singapore Hepatitis Conference

6-7 June 2014, Singapore

The Singapore Hepatitis Conference is a truly historic event. Being held from 6-7 June 2014, this inaugural meeting will disseminate the latest developments in Hepatitis B and C. Held in conjunction with the highly regarded Paris Hepatitis Conference, the Singapore edition will feature the latest developments from the field – with a special emphasis on issues of relevance to professionals practicing in the Far East:

• How to optimize current therapy of HCV patients in Asia

• Differences in Approaches to HCV therapy - West vs. East

• Understanding healthcare systems in Asia

• The scope of HBV related liver disease in Asia

• Cost Effectiveness of HBV therapy in Asia

In addition to the above, the Conference will feature - a single session format, keynote lectures, clinical case studies, and so on. We also welcome the submission of abstracts for consideration for oral or poster presentations.

Join experts from across the region for a conference that will offer an independent, high-level postgraduate educational program that’s tailored for specialists who provide care for patients living with Viral hepatitis.

Hepatologist, Physician, Physician Researcher
Viral Hepatitis Congress 2014
Germany
10/09/2014

Viral Hepatitis Congress 2014

9–11 October 2014 Frankfurt, Germany

Hepatologist, Physician Researcher, Virologist
Digestive Disease Week
United States
Illinois
05/03/2014

Digestive Disease Week

May 3-6, 2014 Chicago, Illinois

Recognized as one of the top 50 medical meetings by the Healthcare Convention & Exhibitors Association, Digestive Disease Week (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.

Whether you work in patient care, research, education or administration, the DDW program offers something for you.

DDW 2014 will be held May 3-6, 2014 at McCormick Place, Chicago, Il.

Gastroenterologist, Hepatologist, Medical Resident, Medical Student, Physician, Physician Researcher, Postdoctoral Fellow, Surgeon
47th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Israel
06/09/2014

47th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)

June 9-12, 2014 Jerusalem, Israel

The scientific programme will include recent advances and state of the art lectures covering genetic, immunological, microbiological and clinical developments in the field of gastrointestinal disorders, liver diseases, and nutrition. There will be many opportunities to discuss and share our clinical and research field interests, to present original works, to see old friends, and to meet new colleagues.

General Information: ESPGHAN2014@mci-group.com

Allied Health Professional, Dietitian, Gastroenterologist, Hepatologist, Nutritionist, Physician, Physician Researcher
5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association
Singapore
03/18/2015

5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association

March 18-21, 2015 Singapore

The 5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) is one of region’s largest medical conferences dedicated to the study of liver, pancreas and biliary discipline. The event provides medical professionals an excellent platform for the exchange of clinical and scientific knowledge on the latest developments and emerging challenges of hepato-pancreato-biliary (HPB) disorders.

The four-day congress will feature an exciting line-up of expert speakers including top practitioners, opinion leaders and researchers. Delegates can look forward to an intensive knowledge-sharing event comprising plenary sessions, oral presentations and video screenings. There will be a host of networking opportunities for delegates to rub shoulders with top experts and opinion leaders.

Congress Secretariat for the 5th Biennial Congress of the Asian-Pacific Hepato-Pancreatro-Biliary Association
Tel: +65 6393 0202
Fax: +65 6292 7577
Email: info@aphpba2015.com
Website: www.aphpba2015.com

Hepatologist, Physician, Physician Researcher
EASL Special Conference: Optimal Management of Hepatitis B Virus Infection
Greece
09/25/2014

EASL Special Conference: Optimal Management of Hepatitis B Virus Infection

September 25-27, 2014 Athens, Greece

We anticipate that this combination of high quality presentations together with the strong reputation of the invited speakers and the relevance of the topics will bring together leading clinicians and scientists involved in Hepatitis B for what will be a memorable meeting.

Hepatologist, Physician, Physician Researcher
EASL Monothematic Conference: Primary Biliary Cirrhosis (PBC)
Italy
05/23/2014

EASL Monothematic Conference: Primary Biliary Cirrhosis (PBC)

May 23-24, 2014 Milan, Italy

The learning objectives:

The objectives of this conference will be to review current finding and address key open questions regarding PBC, such as:

The real role of genetics and epigenetics in the development of the disease

Why there are large geographical variations in disease frequency across Europe

Why PBC occurs predominantly in women

What causes disabling symptoms such as fatigue

Why the autoimmune attack is focused on the biliary epithelium

New theories on potential environmental triggers, such as chemical xenobiotics, will be explored together with the processes within the unique immunological milieu of the liver which lead to the breaking of self-tolerance

Currently described animal models of PBC

Hepatologist, Physician, Physician Researcher